Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
I-Mab Presents Phase 1 Data on Highly Differentiated CD73 Antibody Uliledlimab at ASCO 2021 2021-05-20 06:00
Gracell Biotechnologies to Present Updated Results of GC012F FasTCAR-enabled BCMA/CD19 Dual-targeting CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma at ASCO 2021 and EHA 2021 2021-05-20 05:15
ThinkCyte Secures $26 million in Series B Financing 2021-05-19 22:00
Legend Capital Announces Successful Closing of Healthcare Continuation Fund 2021-05-19 09:01
Firmenich Enters Strategic Partnership with Essential Labs, LLC, a Leading B2B E-Commerce Supplier of Fragrance Solutions 2021-05-18 23:00
Firmenich Enters Strategic Partnership with Essential Labs, LLC, a Leading B2B E-Commerce Supplier of Fragrance Solutions 2021-05-18 23:00
Dinova and Metronom Health, an innovative glucose monitoring company, announces launch of a joint venture in China 2021-05-18 23:00
Eurofins Discovery Launches Human Immune Models for COVID-19 New Therapeutic Discovery or Repurposing 2021-05-18 21:00
Firmenich Unveils Innovative Natural Solution to Recreate Meat-like Juiciness in Plant-based Alternatives 2021-05-18 20:00
Nanoform's final clinical results confirm value proposition to the pharma industry 2021-05-18 13:48
Clover Announces Positive Preclinical Data for Second-Generation Protein-Based COVID-19 Vaccine Candidate Demonstrating Broad Neutralization Against Variants of Concern 2021-05-18 11:50
Mycenax becomes Taiwan's first CDMO company to complete the CHO-S and CHOZN GS Cell Line Development with the Beacon(R) Optofluidic System 2021-05-18 10:32
Hummingbird Bioscience Raises US$125 Million in Series C Financing 2021-05-18 09:35
JA Worldwide Inducts 2021 Laureates into the Global Business Hall of Fame 2021-05-18 04:46
JA Worldwide Inducts 2021 Laureates into the Global Business Hall of Fame 2021-05-18 01:10
EpiVax Identifies T cell Epitopes critical to robust T cell immune response in SARS-CoV-2 , Results Published in NPJ Vaccines 2021-05-17 20:54
Antengene and Calithera Biosciences Enter into Worldwide Exclusive License Agreement to Develop and Commercialize CD73 Inhibitor CB-708 (ATG-037) 2021-05-17 20:35
INOVIO Announces Appointment Of Roger Dansey, M.D., to its Board of Directors 2021-05-17 20:00
Antengene Announces the Completion of the Quantitative and Systems Pharmacology Modeling for ATG-101 in Preparation for First-in-Human Trial 2021-05-17 08:00
China Pharma Holdings, Inc. Reports 33% YoY Increase in First Quarter 2021 Revenue 2021-05-15 04:30